2024 annual financial data
NRX Pharmaceuticals 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -19,704,000 USD and net income was -25,126,000 USD.
Operating cash flow was -10,637,000 USD.
Get free NRX Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -19,704,000 USD
- Net income
- -25,126,000 USD
- Operating cash flow
- -10,637,000 USD